Plasma Indoleamine 2,3-Dioxygenase Concentration is Increased in Hemodialysis Patients and May Contribute to the Pathogenesis of Coronary Heart Disease

REFERENCES

• Parfrey PS, Foley RN. The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol. 1999;10:1606–1615.
   PubMed Web of Science ®Google Scholar
• Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int. 2003;63:793–808.
   PubMed Web of Science ®Google Scholar
• Koenig P, Nagl C, Neurauter G, Schennach H, Brandacher G, Fuchs D. Enhanced degradation of tryptophan in patients on hemodialysis. Clin Nephrol. 2010;74:465–470.
   PubMed Web of Science ®Google Scholar
• Schefold JC, Zeden JP, Fotopoulou C, . Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: A possible link between chronic inflammation and uraemic symptoms. Nephrol Dial Transplant. 2009;24:1901–1908.
   PubMed Web of Science ®Google Scholar
• Pawlak K, Brzosko S, Mysliwiec M, Pawlak D. Kynurenine quinolinic acid—the new factors linked to carotid atherosclerosis in patients with end-stage renal disease. Atherosclerosis. 2009;204:561–566.
   PubMed Web of Science ®Google Scholar
• Kato A, Suzuki Y, Suda T, . Relationship between an increased serum kynurenine/tryptophan ratio and atherosclerotic parameters in hemodialysis patients. Hemodial Int. 2010;14:418–424.
   PubMed Web of Science ®Google Scholar
• King NJ, Thomas SR. Molecules in focus: Indoleamine 2,3-dioxygenase. Int J Biochem Cell Biol. 2007;39:2167–2172.
   PubMed Web of Science ®Google Scholar
• Curti A, Trabanelli S, Salvestrini V, Baccarani M, Lemoli RM. The role of indoleamine 2,3-dioxygenase in the induction of immune tolerance: Focus on hematology. Blood. 2009;113:2394–2401.
   PubMed Web of Science ®Google Scholar
• Thomas SR, Stocker R. Redox reactions related to indoleamine 2,3-dioxygenase and tryptophan metabolism along the kynurenine pathway. Redox Rep. 1999;4:199–220.
   PubMed Web of Science ®Google Scholar
• Sharma MD, Hou DY, Liu Y, . Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes. Blood. 2009;113:6102–6111.
   PubMed Web of Science ®Google Scholar
• Eleftheriadis T, Liakopoulos V, Antoniadi G, Stefanidis I, Galaktidou G. Indolemanine 2,3-dioxygenase is increased in hemodialysis patients and affects immune response to hepatitis B vaccination. Vaccine. 2011;29:2242–2247.
   PubMed Web of Science ®Google Scholar
• Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 1999;55:648–658.
   PubMed Web of Science ®Google Scholar
• Niinisalo P, Oksala N, Levula M, . Activation of indoleamine 2,3-dioxygenase-induced tryptophan degradation in advanced atherosclerotic plaques: Tampere vascular study. Ann Med. 2010;42:55–63.
   PubMed Web of Science ®Google Scholar
• Wirleitner B, Rudzite V, Neurauter G, . Immune activation and degradation of tryptophan in coronary heart disease. Eur J Clin Invest. 2003;33:550–554.
   PubMed Web of Science ®Google Scholar
• Pertovaara M, Raitala A, Juonala M, . Indoleamine 2,3-dioxygenase enzyme activity correlates with risk factors for atherosclerosis: The Cardiovascular Risk in Young Finns Study. Clin Exp Immunol. 2007;148:106–111.
   PubMed Web of Science ®Google Scholar
• Pedersen ER, Midttun O, Ueland PM, . Systemic markers of interferon γ mediated immune activation and long-term prognosis in patients with stable coronary artery disease. Arterioscler Thromb Vasc Biol. 2011;31:698–704.
   PubMed Web of Science ®Google Scholar
• Barth MC, Ahluwalia N, Anderson TJ, . Kynurenic acid triggers firm arrest of leukocytes to vascular endothelium under flow conditions. J Biol Chem. 2009;284:19189–19195.
   PubMed Web of Science ®Google Scholar
• Saito K, Fujigaki S, Heyes MP, . Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency. Am J Physiol Renal Physiol. 2000;279:F565–F572.
   Web of Science ®Google Scholar
• Pawlak D, Tankiewicz A, Matys T, Buczko W. Peripheral distribution of kynurenine metabolites and activity of kynurenine pathway enzymes in renal failure. J Physiol Pharmacol. 2003;54:175–189.
   PubMed Web of Science ®Google Scholar
• Eleftheriadis T, Antoniadi G, Liakopoulos V, Kartsios C, Stefanidis I. Disturbances of acquired immunity in hemodialysis patients. Semin Dial. 2007;20:440–451.
   PubMed Web of Science ®Google Scholar
• Eleftheriadis T, Kartsios C, Yiannaki E, . Chronic inflammation and T cell zeta-chain downregulation in hemodialysis patients. Am J Nephrol. 2008;28:152–157.
   PubMed Web of Science ®Google Scholar
• Eleftheriadis T, Kartsios C, Yiannaki E, . Chronic inflammation and CD16+ natural killer cell zeta-chain downregulation in hemodialysis patients. Blood Purif. 2008;26:317–321.
   PubMed Web of Science ®Google Scholar
• Patsalas S, Eleftheriadis T, Spaia S, . The value of computed tomography-derived coronary artery calcification score in coronary artery disease detection in asymptomatic hemodialysis patients. Ren Fail. 2005;27:683–688.
   PubMed Web of Science ®Google Scholar
• Kushner I. Regulation of the acute phase response by cytokines. Perspect Biol Med. 1993;36:611–622.
   PubMed Web of Science ®Google Scholar
• Pertovaara M, Heliovaara M, Raitala A, Oja SS, Knekt P, Hurme M. The activity of the immunoregulatory enzyme indoleamine 2,3-dioxygenase is decreased in smokers. Clin Exp Immunol. 2006;145:469–473.
   PubMed Web of Science ®Google Scholar
• Wejksza K, Rzeski W, Turski WA. Kynurenic acid protects against the homocysteine-induced impairment of endothelial cells. Pharmacol Rep. 2009;61:751–756.
   PubMed Web of Science ®Google Scholar
• Wang Y, Liu H, McKenzie G, . Kynurenine is an endothelium-derived relaxing factor produced during inflammation. Nat Med. 2010;16:279–285.
   PubMed Web of Science ®Google Scholar
• Fallarino F, Grohmann U, You S, . The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells. J Immunol. 2006;176:6752–6761.
   PubMed Web of Science ®Google Scholar
• Muller AJ, Sharma MD, Chandler PR, . Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3‐dioxygenase. Proc Natl Acad Sci USA. 2008;105:17073–17078.
   PubMed Web of Science ®Google Scholar